CenTrial Logo

Green-Light Filtering Eyeglasses for Fibromyalgia Pain Relief?

by


Clinical trial finds that green-light filtering eyeglasses had no effect on reduding opioid use in fibromyalgia patients

Fibromyalgia is a chronic and often misunderstood medical condition characterized by widespread pain throughout the body, accompanied by fatigue, sleep disturbances, and cognitive issues referred to as "fibro fog." The exact cause of fibromyalgia remains unclear, making it challenging to diagnose. Symptoms can vary from person to person, and there is no known cure. Instead, treatment focuses on managing symptoms through medications, physical therapy, exercise, and lifestyle adjustments. Living with fibromyalgia can be physically and emotionally challenging, but with proper support and care, many individuals can improve their quality of life and manage their symptoms effectively.

Chronic pain management often relies heavily on opioid medications, but there's a growing need for alternative approaches to reduce the risks associated with opioids. Opioids can be addictive and may lead to more problems than solutions for fibromyalgia patients.

Clinical Trial

clinical trial explored the feasibility of using green-light filtering eyeglasses as a potential non-opioid treatment for fibromyalgia-related chronic pain. The researchers recruited adult fibromyalgia patients and randomly assigned them to one of three groups: clear eyeglasses (control), green-light filtering eyeglasses, or blue-light filtering eyeglasses.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

Results

One-third of the green-light filtering eyeglass participants experienced a clinically meaningful reduction (>= 10%) in oral morphine equivalents, compared to 11% in the blue eyeglass group and 8% in the control group.

Significance

While this study primarily aimed to assess the feasibility of using green-light filtering eyeglasses, the reduction in opioid use observed in the green-light filtering eyeglass group suggests further investigation. Future large-scale trials could explore the efficacy of green light-based analgesia in mitigating opioid use, managing pain, and addressing anxiety among fibromyalgia patients. Although the reduction in opioid use wasn't statistically significant, it holds clinical significance, as patients reported no increase in pain.

Conclusion

This study lays the groundwork for potential non-pharmacological interventions in chronic pain management, highlighting the feasibility of green-light filtering eyeglasses. Further research could reveal whether green-light filtering eyeglasses have a meaningful impact on pain relief and opioid reduction, offering hope for safer and more effective ways to manage chronic pain, especially in conditions like fibromyalgia.
__________



Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Without participants there can be no clinical trials.
Without clinical trials there will be no new treatments.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.